Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. [electronic resource]
Producer: 20040304Description: 66-71 p. digitalISSN:- 1526-632X
- Aged
- Alzheimer Disease -- drug therapy
- Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
- Apolipoprotein E4
- Apolipoproteins E -- genetics
- Cyclooxygenase 2
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors -- adverse effects
- Disease Progression
- Double-Blind Method
- Female
- Humans
- Isoenzymes -- antagonists & inhibitors
- Lactones -- adverse effects
- Male
- Membrane Proteins
- Neuropsychological Tests
- Prostaglandin-Endoperoxide Synthases
- Severity of Illness Index
- Sulfones
- Treatment Failure
- United States
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.